Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

People with mild sleep apnea may ... in treating obstructive sleep apnea. Some steps that a person can take to lose weight include: In addition to lifestyle changes that promote weight loss ...

Zepbound (tirzepatide) is a prescription drug that’s used for weight loss and obstructive ... Zepbound is also prescribed to treat moderate to severe obstructive sleep apnea in adults with ...

As more doctors and patients turn to the latest weight-loss ... drugs can reduce the risk of liver and kidney symptoms as well. And Zepbound is approved to reduce the risk of obstructive sleep ...

According to The New York Times, the most popular of the drugs ... approved to treat sleep apnea, Medicare covers Zepbound for that purpose. It does not cover it solely for weight loss.

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

Also, it is known that if taken for weight loss, the drug will likely be taken for life. But Dr. Malhotra says research is still out on whether the same goes for treating sleep apnea. Other CPAP ...

While initially developed to treat Type 2 diabetes, GLP-1 drugs have surged in popularity for their ability to drive substantial weight loss ... conditions like sleep apnea and heart disease.

Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says.

WEDNESDAY, May 14, 2025 (HealthDay News) — More U.S. teenagers are getting weight-loss surgery, despite the discovery of new ...